SCHEMBL18541069

SCHEMBL18541069

COC(=O)N1CCN(C(=O)[C@@H]2CN(c3ccc([N+](=O)[O-])c(C)c3)[C@@H](C)O2)CC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 3/20 0.37
POLB P06746 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
DCTPP1 Q9H773 2/20 0.36
SIRT6 Q8N6T7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18541078 0.90 MAPT (0.43) ALDH1A1MEN1KMT2AL3MBTL1RAB9A
SCHEMBL18527957 0.87 HPGD (0.38) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL18527679 0.87 HPGD (0.38) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL31092268 0.87 HPGD (0.38) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL18541080 0.87 SIRT6 (0.44) ALDH1A1MEN1KMT2ARAB9AMAPT
SCHEMBL18540941 0.81 HPGD (0.49) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL18540940 0.79 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL18527753 0.77 MAPT (0.41) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL31092154 0.77 MAPT (0.41) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL18527993 0.77 SIRT6 (0.43) ALDH1A1MEN1KMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809583-B2 Oxazolidine-based compound and selective androgen receptor agonist comprising same DONG-A ST CO., LTD. (KR) 2017-11-07 US disclosed
US-20170050955-A1 OXAZOLIDINE-BASED COMPOUND AND SELECTIVE ANDROGEN RECEPTOR AGONIST COMPRISING SAME DONG-A ST CO., LTD. (KR) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050955-A1 OXAZOLIDINE-BASED COMPOUND AND SELECTIVE ANDROGEN RECEPTOR AGONIST COMPRISING SAME AR, SHBG, MUSK ALDH1A1 1632/4885MEN1 3697/4885KMT2A 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.